Warning Letter Roundup & Recap – March 8, 2016
This article was originally published in The Gray Sheet
Repro-Med Systems, maker of infusion pumps and intravascular administration sets, was cited for quality systems, Medical Device Reporting and premarket regulation violations. The firm received the only device warning letter listed by FDA this week.
You may also be interested in...
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.
Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.